99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
73

Ric Edelman - The Financial Implications of Alzheimer’s Disease (part 2)

Long-term and health care costs for people living with Alzheimer's and other dementias are projected to reach $360 billion in the Unites States this year

LISTEN NOW
72

Ric Edelman - The Financial implications of Alzheimer’s Disease

Alzheimer’s disease can devastate families financially and requires smart financial planning for healthy longevity. Investment Advisor and New York Times bestselling author Ric Edelman and

LISTEN NOW
71

Drs. Dean and Ayesha Sherzai – Lifestyle and Longevity (part 2)

When it comes to brain health, it can be information overload. Drs. Dean and Ayesha Sherzai, co-directors of the Brain Health and Alzheimer's Prevention Program

LISTEN NOW
70

Dean and Ayesha Sherzai – Lifestyle and Longevity (part 1)

Can small adjustments to lifestyle make a difference for healthy longevity? In this episode of BrainStorm by UsAgainstAlzheimer's, host Meryl Comer focuses on Alzheimer’s prevention

LISTEN NOW
69

Music and Mind Series – Part 3 with Connie Tomaino

How does someone with a movement disorder that effects executive functioning suddenly move to music with a dance tempo?  Concetta M. Tomaino, Executive Director and

LISTEN NOW